← Back to headlines
AC Immune Stock Rises After Amending Licensing Deal with Lilly
AC Immune's stock experienced a rise after the company announced an amendment to its licensing deal with pharmaceutical giant Eli Lilly.
7 Apr, 14:45 — 7 Apr, 14:45
Sources
Showing 1 of 1 sources
